Table 5.
Comparison of prevalence or number of present cardiometabolic disorders between non-locomotive and locomotive syndromea
| Non-LSb | LSc | P value | ||
|---|---|---|---|---|
| NHTd (153) | 128 (83.7 %) | 25 (16.3 %) | 0.0482 | |
| HTe (12) | 8 (66.7 %) | 4 (33.3 %) | ||
| NDMf (142) | 116 (81.7 %) | 26 (18.3 %) | 0.1364 | |
| DMg (23) | 20 (87.0 %) | 3 (13.0 %) | ||
| NHLh (106) | 92 (86.8 %) | 14 (13.2 %) | 0.5382 | |
| HLi (59) | 44 (74.6 %) | 15 (25.4 %) | ||
| NOBj (120) | 106 (88.3 %) | 14 (11.7 %) | 0.0011 | |
| OBk (45) | 30 (66.7 %) | 15 (33.3 %) | ||
| Number of cardiometabolic disorders | 0 (76) | 67 (88.2 %) | 9 (11.8 %) | 0.0526 |
| 1 (52) | 44 (84.6 %) | 8 (15.4 %) | ||
| 2 (26) | 18 (69.2 %) | 8 (30.8 %) | ||
| ≥3 (11) | 7 (63.6 %) | 4 (36.4 %) | ||
aLocomotive Syndrome: GLFS-25 score ≥16 points; b Non-LS non-locomotive syndrome, c LS locomotive syndrome, d NHT non-hypertension, e HT hypertension, f NDM non-diabetes, g DM diabetes, h NHL non-hyperlipidemia, i HL hyperlipidemia, j NOB non-obesity (BMI <25 kg/m2), k OB obesity (BMI ≥25 kg/m2)